All stock lists
Faeth Therapeutics, Inc. (NASDAQ:FTH)
US · Delayed Price · Currency is USD
Also listed: SNSEHealthcare · Biotechnology
19.65+0.42 (+2.18%)
Market cap
$507M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 4, 2021
Website
Insider Score
––Not scored
FTH Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
FTH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New FTH patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to FTH from public contracts
Source: USAspending.gov
Recently reported changes in FTH holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing FTH, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for FTH. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.